Cytokines in the viviparous reproduction of squamate reptiles: interleukin-1 alpha (IL-1 alpha) and IL-1 beta in placental structures of a skink.

PubWeight™: 0.82‹?›

🔗 View Article (PMID 7792282)

Published in Placenta on March 01, 1995

Authors

L Paulesu1, R Romagnoli, M Marchetti, M Cintorino, P Ghiara, F M Guarino, G Ghiara

Author Affiliations

1: Institute of General Physiology, University of Siena, Italy.

Articles by these authors

cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sci U S A (1996) 16.69

Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease. J Exp Med (1994) 6.24

Development of a mouse model of Helicobacter pylori infection that mimics human disease. Science (1995) 5.73

Potential role of molecular mimicry between Helicobacter pylori lipopolysaccharide and host Lewis blood group antigens in autoimmunity. Infect Immun (1996) 2.75

Helicobacter pylori-induced mucosal inflammation is Th1 mediated and exacerbated in IL-4, but not IFN-gamma, gene-deficient mice. J Immunol (2000) 2.54

Expression and localization of ATP binding cassette transporter A1 (ABCA1) in first trimester and term human placenta. Placenta (2010) 2.09

A novel leader peptide which allows efficient secretion of a fragment of human interleukin 1 beta in Saccharomyces cerevisiae. EMBO J (1987) 2.05

Role of the Helicobacter pylori virulence factors vacuolating cytotoxin, CagA, and urease in a mouse model of disease. Infect Immun (1995) 1.93

Unravelling the pathogenic role of Helicobacter pylori in peptic ulcer: potential new therapies and vaccines. Trends Biotechnol (1994) 1.74

Protein expression profiles in human breast ductal carcinoma and histologically normal tissue. Electrophoresis (1997) 1.74

Chronic musculoskeletal pain and depressive symptoms in the National Health and Nutrition Examination. I. Epidemiologic follow-up study. Pain (1993) 1.72

Therapeutic intragastric vaccination against Helicobacter pylori in mice eradicates an otherwise chronic infection and confers protection against reinfection. Infect Immun (1997) 1.57

Possible donor-recipient bartonellosis transmission in a pediatric liver transplant. Transpl Infect Dis (2008) 1.49

Protection against Helicobacter pylori infection in mice by intragastric vaccination with H. pylori antigens is achieved using a non-toxic mutant of E. coli heat-labile enterotoxin (LT) as adjuvant. Vaccine (1998) 1.49

Diagnostic and clinical relevance of the number of circulating CD34(+) cells in myelofibrosis with myeloid metaplasia. Blood (2001) 1.45

Identification of Hürthle cell tumor by single-injection, double-phase scintigraphy with technetium-99m-sestamibi. J Nucl Med (1995) 1.45

Coagulation and cancer: biological and clinical aspects. J Thromb Haemost (2013) 1.42

Clinical management of myelodysplastic syndromes: update of SIE, SIES, GITMO practice guidelines. Leuk Res (2010) 1.40

Walking index for spinal cord injury (WISCI): an international multicenter validity and reliability study. Spinal Cord (2000) 1.40

Distinctive integrin expression in the newly forming epidermis during wound healing in humans. J Invest Dermatol (1993) 1.39

A(3) adenosine receptor ligands: history and perspectives. Med Res Rev (2000) 1.35

Polymorphonuclear leukocyte activation and hemostasis in patients with essential thrombocythemia and polycythemia vera. Blood (2000) 1.34

MR of benign peripheral nerve sheath tumors. J Comput Assist Tomogr (1991) 1.34

Proposed definition of 'poor mobilizer' in lymphoma and multiple myeloma: an analytic hierarchy process by ad hoc working group Gruppo ItalianoTrapianto di Midollo Osseo. Bone Marrow Transplant (2011) 1.32

A short synthetic peptide fragment of human interleukin 1 with immunostimulatory but not inflammatory activity. J Immunol (1986) 1.30

Esophageal replacement: gastric tube or whole stomach? Ann Thorac Surg (1995) 1.30

Relationship between the anti-phospholipase and anti-inflammatory effects of glucocorticoid-induced proteins. Eur J Pharmacol (1984) 1.28

Terminalized semimechanical side-to-side suture technique for cervical esophagogastrostomy. Ann Thorac Surg (1998) 1.27

Kinetic studies on rifampicin. I. Serum concentration analysis in subjects treated with different oral doses over a period of two weeks. Chemotherapy (1971) 1.20

The denervated stomach as an esophageal substitute is a contractile organ. Ann Surg (1998) 1.17

Neutrophil activation and hemostatic changes in healthy donors receiving granulocyte colony-stimulating factor. Blood (1999) 1.17

The efficiency of walking of paraplegic patients using a reciprocating gait orthosis. Paraplegia (1995) 1.16

Gene structure, localization and role in oxidative stress of methionine sulfoxide reductase A (MSRA) in the monkey retina. Exp Eye Res (2005) 1.15

Cost of walking and locomotor impairment. J Electromyogr Kinesiol (1999) 1.15

[(3)H]MRE 3008F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A(3) adenosine receptors. Mol Pharmacol (2000) 1.12

Macrophage migration inhibitory factor in the human endometrium: expression and localization during the menstrual cycle and early pregnancy. Biol Reprod (2001) 1.12

Human peritoneal mesothelial cells produce many cytokines (granulocyte colony-stimulating factor [CSF], granulocyte-monocyte-CSF, macrophage-CSF, interleukin-1 [IL-1], and IL-6) and are activated and stimulated to grow by IL-1. Blood (1992) 1.12

Denervated stomach as an esophageal substitute recovers intraluminal acidity with time. Ann Surg (2001) 1.11

A conventional beagle dog model for acute and chronic infection with Helicobacter pylori. Infect Immun (1999) 1.09

Safety and efficacy of thalidomide in patients with myelofibrosis with myeloid metaplasia. Br J Haematol (2001) 1.08

Mitochondrial complex I defects in aging. Mol Cell Biochem (1997) 1.08

Static and ELF magnetic fields induce tumor growth inhibition and apoptosis. Bioelectromagnetics (2001) 1.07

Differential binding of IL-1 alpha and IL-1 beta to receptors on B and T cells. FEBS Lett (1989) 1.05

In vitro generated mast cells express natural cytotoxicity against tumour cells. Immunology (1985) 1.05

Deciding when to intervene: a Markov decision process approach. Int J Med Inform (2000) 1.04

Synthesis and biological effects of a new series of 2-amino-3-benzoylthiophenes as allosteric enhancers of A1-adenosine receptor. Bioorg Med Chem Lett (2000) 1.04

Design, synthesis, DNA binding, and biological evaluation of water-soluble hybrid molecules containing two pyrazole analogues of the alkylating cyclopropylpyrroloindole (CPI) subunit of the antitumor agent CC-1065 and polypyrrole minor groove binders. J Med Chem (2001) 1.04

Macrophage migration inhibitory factor in prostatic adenocarcinoma: correlation with tumor grading and combination endocrine treatment-related changes. Prostate (2000) 1.04

The Italian multi-centre project on evaluation of MRI and other imaging modalities in early detection of breast cancer in subjects at high genetic risk. J Exp Clin Cancer Res (2002) 1.02

Natural distribution and occurrence of coenzyme Q homologues. Membr Biochem (1992) 1.02

An interlaboratory study to determine the presence of human papillomavirus DNA in esophageal carcinoma from China. Int J Cancer (1999) 1.02

Skeletonizing en bloc esophagectomy for cancer. Ann Surg (2001) 1.01

The interplay of muscular and external forces in human ambulation. J Biomech (1976) 1.00

Static and ELF magnetic fields enhance the in vivo anti-tumor efficacy of cis-platin against lewis lung carcinoma, but not of cyclophosphamide against B16 melanotic melanoma. Pharmacol Res (2003) 1.00

Differential activity of interleukin 1 alpha and interleukin 1 beta in the stimulation of the immune response in vivo. Eur J Immunol (1990) 1.00

Human papillomavirus involvement in esophageal carcinogenesis in the high-incidence area of China. A study of 700 cases by screening and type-specific in situ hybridization. Scand J Gastroenterol (2000) 1.00

Synthesis and biological activity of a new series of N6-arylcarbamoyl, 2-(Ar)alkynyl-N6-arylcarbamoyl, and N6-carboxamido derivatives of adenosine-5'-N-ethyluronamide as A1 and A3 adenosine receptor agonists. J Med Chem (1998) 0.99

Duodenogastric reflux of bile in health: the normal range. Physiol Meas (1999) 0.98

Evaluation of HPV, CMV, HSV and EBV in esophageal squamous cell carcinomas from a high-incidence area of China. Anticancer Res (2001) 0.98

Studies on the biological effects of ozone: 2. Induction of tumor necrosis factor (TNF-alpha) on human leucocytes. Lymphokine Cytokine Res (1991) 0.98

Malignant tumors of the osteogenic matrix. Eur J Radiol (1998) 0.97

Expression of macrophage migration inhibitory factor transcript and protein by first-trimester human trophoblasts. Biol Reprod (1999) 0.97

Antiangiogenic and immunomodulatory effects of rapamycin on islet endothelium: relevance for islet transplantation. Am J Transplant (2006) 0.97

Defibrotide reduces procoagulant activity and increases fibrinolytic properties of endothelial cells. Leukemia (2003) 0.97

[Biological role of folic acid]. Acta Vitaminol Enzymol (1971) 0.96

Pathogenesis of posterior capsular opacification. Part II: Histopathological and in vitro culture findings. J Cataract Refract Surg (1990) 0.96

Vitamin B6 deficiency affects antioxidant defences in rat liver and heart. Biochem Mol Biol Int (1998) 0.95

Autocrine interleukin-1 beta regulates both proliferation and apoptosis in EL4-6.1 thymoma cells. Blood (1995) 0.95

Detoxification of the Helicobacter pylori cytotoxin. Infect Immun (1997) 0.95

Altered glutathione anti-oxidant metabolism during tumor progression in human renal-cell carcinoma. Int J Cancer (2001) 0.94

A cytochemical study of phaeomelanin formation in feather papillae of New Hampshire chick embryos. Experientia (1969) 0.94

Weekly chemotherapy in advanced prostatic cancer. Br J Cancer (1993) 0.93

In vivo stimulation and restoration of the immune response by the noninflammatory fragment 163-171 of human interleukin 1 beta. J Exp Med (1988) 0.93

Coronally advanced flap for the treatment of buccal gingival recessions with and without enamel matrix derivative. A split-mouth study. J Periodontol (2000) 0.93

Heller-Dor procedure for achalasia: from conventional to video-endoscopic surgery. Acta Chir Belg (1996) 0.93

Effects of lipiodol retention on MRI signal intensity from hepatocellular carcinoma and surrounding liver treated by chemoembolization. Eur Radiol (1997) 0.93

[Hepatic arterial vascular anatomy and its variants]. Radiol Med (2000) 0.93

Pathogenesis of Helicobacter pylori and perspectives of vaccine development against an emerging pathogen. Behring Inst Mitt (1994) 0.92

Biomechanics of sit-up exercises. Med Sci Sports Exerc (1981) 0.92

Distinct inhibition of membrane-bound and lysosomal phospholipase A2 by glucocorticoid-induced proteins. Biochem Pharmacol (1984) 0.92

Asymmetric polymeric membranes as a possible model of biological membranes. Biochim Biophys Acta (1967) 0.92

Roux-en-Y jejunal loop and bile reflux. Am J Surg (2000) 0.91

Novel benzoyl nitrogen mustard derivatives of pyrazole analogues of distamycin A: synthesis and antileukemic activity. Bioorg Med Chem (1999) 0.91

Mitochondrial activities of rat heart during ageing. Mech Ageing Dev (1994) 0.91

Helicobacter pylori infection in wild-type and cytokine-deficient C57BL/6 and BALB/c mouse mutants. Microbes Infect (2000) 0.90

Endocrine activity of the corpus luteum and placenta during pregnancy in Chalcides chalcides (Reptilia, Squamata). Gen Comp Endocrinol (1998) 0.90

Pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives as highly potent and selective human A(3) adenosine receptor antagonists: influence of the chain at the N(8) pyrazole nitrogen. J Med Chem (2000) 0.89

Protective effect of exogenous coenzyme Q against damage by adriamycin in perfused rat liver. Biochem Mol Biol Int (1994) 0.89

Thymic hyperplasia and lung carcinomas in a line of mice transgenic for keratin 5-driven HPV16 E6/E7 oncogenes. Oncogene (2001) 0.89

Folate metabolism in the rat liver during regeneration after partial hepatectomy. Biochem J (1975) 0.89

Obstetric complications in patients with depression--a population-based case-control study. J Affect Disord (2000) 0.89

Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives as highly potent and selective human A(3) adenosine receptor antagonists. J Med Chem (1999) 0.89

Ischemic preconditioning (IP) of the liver as a safe and protective technique against ischemia/reperfusion injury (IRI). Am J Transplant (2009) 0.89

Spontaneous rupture of the spleen: report of two cases. Abdom Imaging (2001) 0.89

Age-related balance changes in hearing-impaired children. Phys Ther (1991) 0.89

Balancing donor and recipient risk factors in liver transplantation: the value of D-MELD with particular reference to HCV recipients. Am J Transplant (2011) 0.88

Endothelial cells express the interleukin-1 receptor type I. Blood (1991) 0.88

Infection of human enterocyte-like cells with rotavirus enhances invasiveness of Yersinia enterocolitica and Y. pseudotuberculosis. J Med Microbiol (2000) 0.88

Mouse model of Helicobacter pylori infection: studies of gastric function and ulcer healing. Aliment Pharmacol Ther (1999) 0.88